Douglas Hutchens
Director/Board Member bei ANIMALCARE GROUP PLC
Profil
Douglas Eugene Hutchens is an Independent Non-Executive Director at Animalcare Group Plc and the Chief Scientific Officer at Animol Discovery.
He was previously a Director at Crenae Therapeutics, Inc. and the Chief Veterinary Officer & Executive VP at Bayer Animal Health.
He also worked as an Assistant Professor at the University of Illinois College of Veterinary Medicine.
Hutchens holds a doctorate degree from the University of Illinois.
Aktive Positionen von Douglas Hutchens
| Unternehmen | Position | Beginn |
|---|---|---|
| ANIMALCARE GROUP PLC | Director/Board Member | 10.02.2022 |
Animol Discovery
 Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Douglas Hutchens
| Unternehmen | Position | Ende |
|---|---|---|
| Crenae Therapeutics, Inc. | Director/Board Member | 01.08.2022 |
Bayer Animal Health
 Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Corporate Officer/Principal | 01.07.2020 |
| University of Illinois College of Veterinary Medicine | Corporate Officer/Principal | - |
Ausbildung von Douglas Hutchens
| University of Illinois | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ANIMALCARE GROUP PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Bayer Animal Health
Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Health Technology |
Animol Discovery
Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Health Technology |
| Crenae Therapeutics, Inc. |
